Tatva Chintan Pharma Chem Limited

NSEI:TATVA 株式レポート

時価総額:₹24.0b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Tatva Chintan Pharma Chem 配当金

配当金 基準チェック /16

Tatva Chintan Pharma Chem配当を支払う会社であり、現在の利回りは0.21%で、収益によって十分にカバーされています。

主要情報

0.2%

配当利回り

15%

配当性向

業界平均利回り0.6%
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金₹2.000
一株当たり利益₹11.14
配当利回り予想0.6%

最近の配当金アップデート

Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Aug 29
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Recent updates

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Sep 26
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Aug 29
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Jul 27
Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

May 11
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

Apr 04
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Jan 26
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

May 10
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Jul 28
Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Jun 17
Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

May 03
Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Dec 06
Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

決済の安定と成長

配当データの取得

安定した配当: 配当金の支払いは安定していますが、 TATVAが配当金を支払っている期間は 10 年未満です。

増加する配当: TATVAは2年間のみ配当金を支払っており、それ以降支払額は増加していません。


配当利回り対市場

Tatva Chintan Pharma Chem 配当利回り対市場
TATVA 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (TATVA)0.2%
市場下位25% (IN)0.2%
市場トップ25% (IN)1.0%
業界平均 (Chemicals)0.6%
アナリスト予想 (TATVA) (最長3年)0.6%

注目すべき配当: TATVAの配当金 ( 0.18% ) はIndian市場の配当金支払者の下位 25% ( 0.27% ) と比べると目立ったものではありません。

高配当: TATVAの配当金 ( 0.18% ) はIndian市場の配当金支払者の上位 25% ( 1.12% ) と比較すると低いです。


株主への利益配当

収益カバレッジ: TATVAは低い 配当性向 ( 15.1% ) であるため、配当金の支払いは利益によって十分にカバーされます。


株主配当金

キャッシュフローカバレッジ: TATVAは配当金を支払っていますが、同社にはフリーキャッシュフローがありません。


高配当企業の発掘